Citation Impact
Citing Papers
T-705 (Favipiravir) Induces Lethal Mutagenesis in Influenza A H1N1 Viruses In Vitro
2013
Rodent-borne diseases and their risks for public health
2009 Standout
Mechanism of the potentiating effect of ribavirin on the activity of 2‘,3‘-dideoxyinosine against human immunodeficiency virus.
1991
Dynasore, a Cell-Permeable Inhibitor of Dynamin
2006 Standout
Quasispecies, Error Catastrophe, and the Antiviral Activity of Ribavirin
2002
Mechanism of action of foscarnet against viral polymerases
1992
New therapies on the horizon for hepatitis C
2003 StandoutNobel
A New Anti-influenza Virus Antibiotic, 10-Norparvulenone from Microsphaeropsis sp. FO-5050.
2000 StandoutNobel
Intracellular metabolism of favipiravir (T-705) in uninfected and influenza A (H5N1) virus-infected cells
2009
Adenovirus infection induces amplification of persistent viral DNA sequences (simian virus 40, hepatitis B virus, bovine papillomavirus) in human and rodent cells
1990 StandoutNobel
SARS and MERS: recent insights into emerging coronaviruses
2016 Standout
Factors underlying spontaneous inactivation and susceptibility to neutralization of human immunodeficiency virus
1992
Molecular Mechanisms of Action of Ribavirin
1990
Development of vaccines and antivirals for combating viral pandemics
2020 StandoutNobel
Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
1998 Standout
Development of antibody-based assays for high throughput discovery and mechanistic study of antiviral agents against yellow fever virus
2020 StandoutNobel
The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen
2000
Antiviral Agents: Characteristic Activity Spectrum Depending on the Molecular Target With Which They Interact
1993
Lethal Mutagenesis of Hepatitis C Virus Induced by Favipiravir
2016 StandoutNobel
Curing of foot-and-mouth disease virus from persistently infected cells by ribavirin involves enhanced mutagenesis
2003
Monitoring of viral susceptibility: new challenges with the development of influenza NA inhibitors
2000
COVID-19: A promising cure for the global panic
2020 Standout
Introduction of Fluorine and Fluorine‐Containing Functional Groups
2013 Standout
Optimization of affinity, specificity and function of designed influenza inhibitors using deep sequencing
2012 StandoutNobel
Metabolism and antiviral activity of ribavirin
2004
Experimental therapies for yellow fever
2012
Use of phosphonocarboxylic acids as inhibitors of sodium-phosphate cotransport
1996
Extinction of Hepatitis C Virus by Ribavirin in Hepatoma Cells Involves Lethal Mutagenesis
2013
Mechanisms of action of ribavirin against distinct viruses
2005
Treating hepatitis C
2005 StandoutNobel
Generation of Hydroxyl Radicals by the Antiviral Compound Phosphonoformic Acid (Foscarnet)
2001
New strategy for discovery of enzyme inhibitors: Screening with intact mammalian cells or intact microorganisms having special functions.
1990 StandoutNobel
Ribavirin - current status of a broad spectrum antiviral agent
2001
Fluorescence probes used for detection of reactive oxygen species
2005 Standout
Dancing with chemical formulae of antivirals: A panoramic view (Part 2)
2013
A Computationally Designed Hemagglutinin Stem-Binding Protein Provides In Vivo Protection from Influenza Independent of a Host Immune Response
2016 StandoutNobel
Techniques for using antisense oligodeoxyribonucleotides to study gene expression
1988
Initial Binding of the Broad Spectrum Antiviral Nucleoside Ribavirin to the Hepatitis C Virus RNA Polymerase
2003
Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis C
1998 Standout
Traditional Chinese Medicine in the Treatment of Patients Infected with 2019-New Coronavirus (SARS-CoV-2): A Review and Perspective
2020 Standout
Synthesis of 1-β-d-ribofuranosyl-3-ethynyl-[1,2,4]triazole and its in vitro and in vivo efficacy against Hantavirus
2008
New therapeutic strategies for hepatitis C
2002 StandoutNobel
Reactions of trimethylsilyl fluorosulfonyldifluoroacetate with purine and pyrimidine nucleosides
2008
The alphaviruses: gene expression, replication, and evolution
1994 Standout
Synthesis of Heterocycles via Electrophilic Cyclization of Alkynes Containing Heteroatom
2011 Standout
Ribavirin: An antiviral agent
1979
New Nucleoside Analogues for the Treatment of Hemorrhagic Fever Virus Infections
2019
Inhibition of hepatitis-B-virus DNA polymerase by phosphonoformate: Studies on its mode of action
1980
Activities of Oseltamivir and Ribavirin Used Alone and in Combination against Infections in Mice with Recent Isolates of Influenza a (H1N1) and B Viruses
2006
An overview of the role of nucleosides in chemotherapy
1985 StandoutNobel
Antisense to LOX-1 Inhibits Oxidized LDL–Mediated Upregulation of Monocyte Chemoattractant Protein-1 and Monocyte Adhesion to Human Coronary Artery Endothelial Cells
2000 Standout
Properties of Herpes simplex virus type 1 and type 2 DNA polymerase
1980
Approaches and Strategies for the Treatment of Influenza Virus Infections
1999
Broad-spectrum antiviral activity of 2-beta-D-ribofuranosylselenazole-4-carboxamide, a new antiviral agent
1983
Varicella-zoster virus
1996 Standout
Chromone: A Valid Scaffold in Medicinal Chemistry
2014 Standout
Preclinical toxicology studies with acyclovir: Acute and subchronic tests
1983 StandoutNobel
An investigation into the identification of potential inhibitors of SARS-CoV-2 main protease using molecular docking study
2020 Standout
Identification of AP80978, a Novel Small-Molecule Inhibitor of Hepatitis C Virus Replication That Targets NS4B
2014 StandoutNobel
Biochemistry and clinical applications of ribavirin
1986
The Unenlarged Lymph Nodes of HIV-1–infected, Asymptomatic Patients with High CD4 T Cell Counts Are Sites for Virus Replication and CD4 T Cell Proliferation. The Impact of Highly Active Antiretroviral Therapy
1998 StandoutNobel
In Vitro and In Vivo Activities of Anti-Influenza Virus Compound T-705
2002
Cyclopentane Neuraminidase Inhibitors with Potent In Vitro Anti-Influenza Virus Activities
2001
Approved Antiviral Drugs over the Past 50 Years
2016
Identification of a Dominant Negative Inhibitor of Human Zinc Finger Antiviral Protein Reveals a Functional Endogenous Pool and Critical Homotypic Interactions
2010 StandoutNobel
Phosphate Regulation of Vascular Smooth Muscle Cell Calcification
2000 Standout
Response of Hepatitis C Virus to Long-Term Passage in the Presence of Alpha Interferon: Multiple Mutations and a Common Phenotype
2013 StandoutNobel
Inhibition of purified human and herpes simplex virus-induced DNA polymerases by 9-(2-hydroxyethoxymethyl)guanine triphosphate. Effects on primer-template function.
1981 StandoutNobel
Therapeutic options for the 2019 novel coronavirus (2019-nCoV)
2020 Standout
Chemistry of Biologically Important Synthetic Organoselenium Compounds
2001 Standout
Increased Replicative Fitness Can Lead to Decreased Drug Sensitivity of Hepatitis C Virus
2014 StandoutNobel
Sindbis virus mutants resistant to mycophenolic acid and ribavirin
1987
Effects of the Combination of Favipiravir (T-705) and Oseltamivir on Influenza A Virus Infections in Mice
2009
Studies on the biosynthesis of bialaphos (SF-1293) 1. Incorporation of 13C- and 2H-labeled precursors into bialaphos.
1982
Internal Disequilibria and Phenotypic Diversification during Replication of Hepatitis C Virus in a Noncoevolving Cellular Environment
2017 StandoutNobel
Interferon-induced human protein MxA is a GTPase which binds transiently to cellular proteins
1992
Identification of a gene function of herpes simplex virus type 1 essential for amplification of simian virus 40 DNA sequences in transformed hamster cells
1984 StandoutNobel
Comparative Efficacy of Antiherpes Drugs against Different Strains of Herpes Simplex Virus
1980
Broad-Spectrum Antiviral Activity of the IMP Dehydrogenase Inhibitor VX-497: a Comparison with Ribavirin and Demonstration of Antiviral Additivity with Alpha Interferon
2000
Antiviral agents as adjuncts in cancer chemotherapy
1980
Prevention and Control of Influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
2001 Standout
Works of S. Stridh being referenced
Synthesis of Adenylyl-(3' -> 5')-guanosine and some Analogues as Probes to Explore the Molecular Mechanism of Stimulation of Influenza Virus RNA Polymerase.
1985
Functional analysis of influenza rna polymerase activity by the use of caps, oligonucleotides and polynucleotides
1981
Determination of ribonucleoside triphosphate pools in influenza A virus-infected MDCK cells
1983
Inhibition of Influenza Virus Ribonucleic Acid Polymerase by Ribavirin Triphosphate
1977
Trisodium Phosphonoformate, a New Antiviral Compound
1978 Science